Intelligent Bio Solutions Inc. financial data

Symbol
INBS on Nasdaq
Location
135 W 41 St St,, Floor 5, New York, NY
Fiscal year end
June 30
Latest financial report
10-K - Q2 2025 - Aug 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99 % -10.7%
Quick Ratio 13.8 % -10.2%
Debt-to-equity 109 % +6.46%
Return On Equity -236 % -36.9%
Return On Assets -111 % -31.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.98M shares
Common Stock, Shares, Outstanding 7.32M shares +112%
Entity Public Float 6.59M USD +10%
Common Stock, Value, Issued 73.2K USD +112%
Weighted Average Number of Shares Outstanding, Basic 5.27M shares +231%
Weighted Average Number of Shares Outstanding, Diluted 5.27M shares +231%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 902K USD -0.61%
Revenue from Contract with Customer, Excluding Assessed Tax 3.05M USD -1.9%
Cost of Revenue 1.81M USD +7.09%
General and Administrative Expense 8.88M USD -4.05%
Operating Income (Loss) -10.6M USD -3.52%
Nonoperating Income (Expense) 39.7K USD -56.9%
Net Income (Loss) Attributable to Parent -10.6M USD -4.06%
Earnings Per Share, Basic -2 USD/shares +68.7%
Earnings Per Share, Diluted -2 USD/shares +68.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.02M USD -83.8%
Accounts Receivable, after Allowance for Credit Loss, Current 595K USD +38.4%
Inventory, Net 635K USD -18.3%
Other Assets, Current 827K USD +66.2%
Assets, Current 4.14M USD -51.5%
Property, Plant and Equipment, Net 251K USD -55.6%
Operating Lease, Right-of-Use Asset 69.5K USD -77.3%
Intangible Assets, Net (Excluding Goodwill) 3.79M USD -13.3%
Assets 8.25M USD -40.1%
Employee-related Liabilities, Current 535K USD +14%
Accrued Liabilities, Current 1.19M USD +96%
Liabilities, Current 5.35M USD -1.83%
Operating Lease, Liability, Noncurrent 3.7K USD -97.6%
Liabilities 5.44M USD -2.85%
Accumulated Other Comprehensive Income (Loss), Net of Tax -328K USD +54%
Retained Earnings (Accumulated Deficit) -62.5M USD -20.3%
Stockholders' Equity Attributable to Parent 3M USD -64%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.81M USD -65.6%
Liabilities and Equity 8.25M USD -40.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.39M USD -82%
Net Cash Provided by (Used in) Financing Activities 42.5K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.32M shares +112%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.31M USD -71.4%
Deferred Tax Assets, Valuation Allowance 12.7M USD +21.8%
Deferred Tax Assets, Gross 12.7M USD +22%
Operating Lease, Liability 84.7K USD -76.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -10.2M USD +1.07%
Lessee, Operating Lease, Liability, to be Paid 86.9K USD -77.8%
Property, Plant and Equipment, Gross 339K USD -45.8%
Operating Lease, Liability, Current 84.7K USD -69.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 83.5K USD -73%
Lessee, Operating Lease, Liability, to be Paid, Year One 86.9K USD -71.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.25K USD -93.8%
Preferred Stock, Shares Issued 0 shares
Additional Paid in Capital 65.8M USD +7.89%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 949K USD +0.2%
Depreciation, Depletion and Amortization 242K USD -2.41%
Deferred Tax Assets, Net of Valuation Allowance 15.2K USD